# Liquidmetal Technologies Inc: overview LQMT · OTC · CIK 1141240 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lqmt.md) · [Financials](/companies/lqmt/financials.md) · [Filings](/companies/lqmt/filings.md) · [Insiders](/companies/lqmt/insiders.md) Latest reported revenue: [$196.0k](/filings/0001437749-26-026257.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-026257). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [316](/filings/0001437749-25-034818.md) | [129 d](/filings/0001437749-26-007965.md) | [282](/filings/0001437749-26-015930.md) | [289](/filings/0001437749-26-026257.md) | [37.0](/filings/0001437749-25-034818.md) | [176 d](/filings/0001437749-26-007965.md) | [256](/filings/0001437749-26-015930.md) | [196](/filings/0001437749-26-026257.md) | | Gross margin | % | [24.4%](/filings/0001437749-25-034818.md) | [35.7% d](/filings/0001437749-26-007965.md) | [27.7%](/filings/0001437749-26-015930.md) | [26.6%](/filings/0001437749-26-026257.md) | [54.1%](/filings/0001437749-25-034818.md) | [31.3% d](/filings/0001437749-26-007965.md) | [30.1%](/filings/0001437749-26-015930.md) | [45.4%](/filings/0001437749-26-026257.md) | | Operating margin | % | [(263.6%)](/filings/0001437749-25-034818.md) | [(732.6%) d](/filings/0001437749-26-007965.md) | [(319.5%)](/filings/0001437749-26-015930.md) | [(294.8%)](/filings/0001437749-26-026257.md) | [(2554.1%)](/filings/0001437749-25-034818.md) | [(592.6%) d](/filings/0001437749-26-007965.md) | [(444.5%)](/filings/0001437749-26-015930.md) | [(604.6%)](/filings/0001437749-26-026257.md) | | Net margin | % | [(139.6%)](/filings/0001437749-25-034818.md) | [(384.5%) d](/filings/0001437749-26-007965.md) | [(201.4%)](/filings/0001437749-26-015930.md) | [(181.3%)](/filings/0001437749-26-026257.md) | [(1491.9%)](/filings/0001437749-25-034818.md) | [(396.0%) d](/filings/0001437749-26-007965.md) | [(298.8%)](/filings/0001437749-26-015930.md) | [(428.6%)](/filings/0001437749-26-026257.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | not reported | [(1,022) d](/filings/0001437749-26-007965.md) | [(299)](/filings/0001437749-26-015930.md) | [(280) d](/filings/0001437749-26-026257.md) | [(749) d](/filings/0001437749-25-034818.md) | [(1,428) d](/filings/0001437749-26-007965.md) | [(541)](/filings/0001437749-26-015930.md) | [(349) d](/filings/0001437749-26-026257.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [811](/filings/0001437749-23-006473.md) | [383](/filings/0001437749-23-006473.md) | [510](/filings/0001437749-25-007519.md) | [860](/filings/0001437749-26-007965.md) | [784](/filings/0001437749-26-007965.md) | | Gross margin | % | [22.6%](/filings/0001437749-23-006473.md) | [17.5%](/filings/0001437749-24-035959.md) | [29.2%](/filings/0001437749-25-007519.md) | [25.2%](/filings/0001437749-26-007965.md) | [29.3%](/filings/0001437749-26-007965.md) | | Operating margin | % | [(500.7%)](/filings/0001437749-23-006473.md) | [(796.9%)](/filings/0001437749-24-035959.md) | [(604.9%)](/filings/0001437749-25-007519.md) | [(385.2%)](/filings/0001437749-26-007965.md) | [(477.3%)](/filings/0001437749-26-007965.md) | | Net margin | % | [(416.4%)](/filings/0001437749-23-006473.md) | [(624.8%)](/filings/0001437749-24-035959.md) | [(401.4%)](/filings/0001437749-25-007519.md) | [(175.6%)](/filings/0001437749-26-007965.md) | [(298.6%)](/filings/0001437749-26-007965.md) | | Diluted EPS | $ per share | [0.00](/filings/0001437749-23-006473.md) | [0.00](/filings/0001437749-24-035959.md) | [0.00](/filings/0001437749-24-035959.md) | not reported | not reported | | Free cash flow | $k | [(2,730)](/filings/0001437749-23-006473.md) | not reported | not reported | [(1,157)](/filings/0001437749-26-007965.md) | [(2,756)](/filings/0001437749-26-007965.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lqmt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [WESBANCO BANK INC](/funds/877134.md) | 2026-06-30 | $123.1k | 620,307 | | Unchanged | | [Byrne Asset Management LLC](/funds/1911322.md) | 2026-06-30 | $80.0k | 400,000 | | New +400,000 | | [Williams Jones Wealth Management, LLC.](/funds/1788587.md) | 2026-06-30 | $3.8k | 19,332 | | New +19,332 | | [King Wealth Management Group](/funds/1568235.md) | 2026-06-30 | $50 | 250,000 | | New +250,000 | ## Recent filings [All 413 filings](/companies/lqmt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 16:08 ET | [10-Q](/filings/0001437749-26-026257.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026257 | | 2026-06-29 | 16:05 ET | [8-K](/filings/0001437749-26-021986.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-26-021986 | | 2026-05-08 | 16:37 ET | [10-Q](/filings/0001437749-26-015930.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015930 | | 2026-03-12 | 16:06 ET | [10-K](/filings/0001437749-26-007965.md) | Annual report, period 2025-12-31 | 0001437749-26-007965 | | 2025-11-13 | 16:08 ET | [10-Q](/filings/0001437749-25-034818.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034818 | | 2025-08-13 | 16:00 ET | [10-Q](/filings/0001437749-25-026496.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026496 | | 2025-07-10 | 16:02 ET | [8-K](/filings/0001437749-25-022526.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-022526 | | 2025-05-29 | 16:02 ET | [8-K](/filings/0001437749-25-018794.md) | 8.01 Other events | 0001437749-25-018794 | | 2025-05-13 | 16:06 ET | [10-Q](/filings/0001437749-25-016434.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016434 | | 2025-03-13 | 16:05 ET | [10-K](/filings/0001437749-25-007519.md) | Annual report, period 2024-12-31 | 0001437749-25-007519 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-007965.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c25ecb8f-6a5a-47d2-bae1-e3268fbb4c41) ## About the filer - CIK: 1141240 - Tickers: LQMT - Exchange: OTC - SIC code: 2800 Chemicals & Allied Products - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.